News
ImmunAbs Announces FDA Phase 2 IND Approval of IM-101, a Novel Complement C5 Inhibitor, for Treatment of Myasthenia Gravis ...
The human body has three primary lines of defense to fight against foreign invaders, including viruses, bacteria, and fungi.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback